We launched Papillomavirus Research to provide a platform for research on HPV and related viruses, collaborating closely with the International Papillomavirus Society.
It offers the HPV research and clinical communities a place to share their work and maintain a high standard of quality in HPV research. It had a very successful first year, receiving close to 80 manuscripts, 50 of which have been published or are being processed.
Bosch anticipates that by the next International Papillomavirus Conference in February , Papillomavirus Research will have been evaluated and accepted in all major indexing and retrieval systems, including Scopus and PubMed. By publishing high quality peer-reviewed content with the latest knowledge about HPV, the journal will also play a role in improving public health and engagement on the topic.
When the HPV vaccine was first introduced a decade ago, it was met with resistance and steeped in controversy. HPV vaccines work best when given to preadolescent girls and boys , before they become sexually active; this is one of the reasons for resistance. Some people claim the vaccine promotes promiscuity by sending the message to young people that there is no danger of getting a sexually transmitted infection.
The HPV vaccine is generating some anti-vaccine reactions and vaccine hesitancy in some countries. This deserves attention; the scientific and public health communities need to monitor introduction and reinforce access to vaccination in all countries worldwide.
Indications need to be regularly updated in light of the latest clinical trials and the evaluation of public programs. We also need to improve our communication with the public, based on sound evidence published in journals like Papillomavirus Research. Bosch is the editor of the international newsletter HPV Today and is Director of an e-learning effort in oncology , which includes e-courses on cervical cancer prevention.
His epidemiological research on cancers linked to infectious agents led him to be involved in demonstrating causality in the HPV and invasive cervical cancer relationship.
He currently works on integrating HPV vaccination and screening in environments with limited resources and disseminating scientific information of clinical relevance. The official journal of the International Papillomavirus Society , PVR is an open access publication that aims to bring together virologists, immunologists, epidemiologists and clinicians working in the booming field of HPV and animal papillomaviruses, polyomaviruses and other small DNA tumor viruses and their associated diseases, in order to foster and facilitate interdisciplinary communication.
This journal is published by Elsevier. A stint in the press office at Imperial saw her stories on the front pages, and she moved to Amsterdam to work at Elsevier as Senior Marketing Communications Manager for Life Sciences.
Tweet her LucyGoodchild. We are always looking for ways to improve customer experience on Elsevier. We would like to ask you for a moment of your time to fill in a short questionnaire, at the end of your visit.
If you decide to participate, a new browser tab will open so you can complete the survey after you have completed your visit to this website. Thanks in advance for your time. About Elsevier. Set via JS. Elsevier Connect.
View by community or topic. Library Connect. Societies' Update. Introducing these VLPs into the body via injection stimulates the body to create the antibodies needed to fight it and clear it from the body. This method of vaccination is highly effective, as the VLPs cause high levels of antibody production. After seven years of design and testing, the first human trials for the vaccine, named Gardasil, were completed. Since then, two further vaccines have been approved: a bivalent vaccine called Cervarix approved in that prevents two HPV types HPV16 and 18 and a nonavalent vaccine called Gardasil 9 in that protects against nine HPV types HPV 6, 11, 16, 18, 31, 33, 45, 52, and As of October , countries worldwide vaccinate against HPV as part of their regular vaccine schedule.
Jun 18, The history of the HPV vaccine. Recent Posts See All. HPV and men- Fact sheet. March 27, De Kok, I. Would the effect of HPV vaccination on non-cervical HPV-positive cancers make the difference for its cost-effectiveness? Eur J Cancer. GAVI Alliance. Human Papillomavirus vaccine support. Kreimer, A. Lancet Oncol.
Meites, E. RRP Foundation. What is recurrent respiratory papillomatosis? Preventive Service Task Force. Cervical cancer: Screening. Villa, L. HPV prophylactic vaccination: The first years and what to expect from now. Cancer Letters. Article Menu [ ]. Vaccine Science [ ]. Biological Weapons, Bioterrorism, and Vaccines. Cancer Vaccines and Immunotherapy.
Careers in Vaccine Research. Ebola Virus Disease and Ebola Vaccines. Human Cell Strains in Vaccine Development. Identifying Pathogens and Transmission Vectors. Malaria and Malaria Vaccine Candidates. Passive Immunization. The Future of Immunization. Vaccines for Pandemic Threats. Viruses and Evolution.
History and Society [ ]. Cultural Perspectives on Vaccination. Disease Eradication. Ethical Issues and Vaccines. History of Anti-vaccination Movements. Influenza Pandemics. The Development of the Immunization Schedule. The History of the Lyme Disease Vaccine. The Scientific Method in Vaccine History. Military and Vaccine History. Vaccination Exemptions.
0コメント